Want to see KIDS full AI Analyst Report?
KIDS Stock Chart & Stats
$24.50
$0.95(5.03%)
At close: 4:00 PM EDT
$24.50
$0.95(5.03%)
Day’s Range― - ―
52-Week Range$14.42 - $26.74
Previous Close$20.42
Volume117.04K
Average Volume (3M)222.14K
Market Cap
$569.72M
Enterprise Value$518.17
Total Cash (Recent Filing)$45.88M
Total Debt (Recent Filing)$91.59M
Price to Earnings (P/E)―
Beta0.68
Next Earnings
Nov 03, 2026EPS Estimate
-0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.68
Shares Outstanding26,109,789
10 Day Avg. Volume208,505
30 Day Avg. Volume222,139
Financial Highlights & Ratios
PEG Ratio-3.45
Price to Book (P/B)1.20
Price to Sales (P/S)1.76
P/FCF Ratio-26.10
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$27.50Price Target Upside12.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)-1.22
Revenue Forecast (FY)$266.98M
Bulls Say, Bears Say
Bulls Say
Specialized Market PositionA pediatric-only focus and dedicated sales network create specialized positioning in a market where adult-focused incumbents leave a competitive gap. Broad hospital access and a portfolio tailored to children can support durable surgeon adoption and expansion across geographies.
Sustained Revenue GrowthStrong quarterly growth combined with raised full-year guidance indicates continuing demand for the company's pediatric orthopedic offerings. Revenue expansion improves operating leverage, funds product investment, and strengthens the platform for additional adoption over the next several quarters.
High Margins And Conservative LeverageHigh gross margins provide meaningful room to absorb commercial investment while retaining economic value from incremental sales. Conservative leverage and a substantial equity base add financial flexibility to fund growth and manage the transition toward sustainable profitability.
Bears Say
Persistent Net LossesThe company has not yet converted strong revenue and gross profit into consistent operating or net earnings. Persistent losses weaken returns on shareholder capital and leave future profitability dependent on continued growth, margin discipline, and operating leverage.
Free Cash Flow Remains NegativeImproved operating cash flow is encouraging, but negative free cash flow shows that reinvestment needs and capital spending still exceed internally generated cash. Until the business becomes consistently self-funding, balance-sheet resources may be needed to support expansion.
Operating Expense PressureHigher sales, marketing, and administrative spending can support clinic expansion, but it also delays earnings conversion when costs rise alongside growth. Sustained expense intensity could limit operating leverage unless new products and adoption generate sufficient incremental revenue.
OrthoPediatrics News
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $14.42 and its highest was $26.74 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
OrthoPediatrics Corp’s market cap is $569.72M.
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Nov 03, 2026 which is in 42 days.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Aug 04, 2026. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.302 by $0.002.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -0.23.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 26,109,789 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.302. Following the earnings report the stock price went up 6.849%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Currently, no hedge funds are holding shares in KIDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OrthoPediatrics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.50 (12.24% Upside)
$27.50 (12.24% Upside)
Blogger Sentiment
Neutral
KIDS Sentiment 50%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 254.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $46.7M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.52%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.55%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
KIDS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed substantial positive momentum: record revenue, record adjusted EBITDA, strong T&D and OPSB growth, material free cash flow improvement, and raised revenue guidance. Challenges were largely timing-related (zero 7D units, Brazil set timing) and temporary foreign exchange headwinds that widened non-GAAP loss per share. Management emphasized disciplined capital allocation and conservatism in guidance while highlighting a multi-year product 'super cycle' that should drive higher-margin, higher-ASP sales over time. On balance, positive operational and financial improvements outweigh the notable but mostly timing- and FX-driven lowlights.View all KIDS earnings summariesKIDS Stock 12 Month Forecast
Average Price Target
$27.50
▲(12.24% Upside)
Technical Analysis
Orthofix Medical
―
Tandem Diabetes Care
―
Varex Imaging
―
Bioventus
―
Treace Medical Concepts
―
Ownership Overview
32.84% Insiders
12.87% Mutual Funds
23.00% Other Institutional Investors
23.29% Public Companies and
Individual Investors